← Back to Clinical Trials
Recruiting NCT07090200

Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Respiratory Diseases
Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-09-01
Completion 2028-07-31
Interventions
Pulmonary Rehabilitation Care GroupThe Routine Care (Non-Pharmacological and Pharmacological Treatments ) Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, to evaluate the therapeutic effect of Pulmonary rehabilitation exercise and usual care for three months. And finally, to build a trinity model of rehabilitation management of COPD patients. The objective of this project is to establish and promote the application of diagnostic and treatment norms.

Eligibility Criteria

Inclusion Criteria: 1. Committed to adhering to the study protocol and cooperating with the implementation of the entire research process. 2. Aged 18 years or older, regardless of gender. 3. Signed informed consent form. Exclusion Criteria: 1. Individuals with severe mental illness. 2. Individuals assessed by medical personnel as having a disease that requires immediate hospitalization or a severe, uncontrollable condition that is life-threatening in the short term. 3. Women who are pregnant, breastfeeding, or using inappropriate contraception methods. 4. Individuals who refuse to cooperate with follow-up questionnaires or specimen collection. 5. Patients currently participating in other interventional clinical drug trials.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}